Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs

Qi Zhao,Hong Zong,Pingping Zhu,Chang Su,Wenxue Tang,Zhenzhen Chen,Shuiling Jin

DOI: https://doi.org/10.1186/s40164-024-00474-x

2024-01-24

Experimental Hematology and Oncology

Abstract:Cancer immunotherapy has emerged as a promising strategy in the treatment of colorectal cancer, and relapse after tumor immunotherapy has attracted increasing attention. Cancer stem cells (CSCs), a small subset of tumor cells with self-renewal and differentiation capacities, are resistant to traditional therapies such as radiotherapy and chemotherapy. Recently, CSCs have been proven to be the cells driving tumor relapse after immunotherapy. However, the mutual interactions between CSCs and cancer niche immune cells are largely uncharacterized. In this review, we focus on colorectal CSCs, CSC-immune cell interactions and CSC-based immunotherapy. Colorectal CSCs are characterized by robust expression of surface markers such as CD44, CD133 and Lgr5; hyperactivation of stemness-related signaling pathways, such as the Wnt/β-catenin, Hippo/Yap1, Jak/Stat and Notch pathways; and disordered epigenetic modifications, including DNA methylation, histone modification, chromatin remodeling, and noncoding RNA action. Moreover, colorectal CSCs express abnormal levels of immune-related genes such as MHC and immune checkpoint molecules and mutually interact with cancer niche cells in multiple tumorigenesis-related processes, including tumor initiation, maintenance, metastasis and drug resistance. To date, many therapies targeting CSCs have been evaluated, including monoclonal antibodies, antibody‒drug conjugates, bispecific antibodies, tumor vaccines adoptive cell therapy, and small molecule inhibitors. With the development of CSC-/niche-targeting technology, as well as the integration of multidisciplinary studies, novel therapies that eliminate CSCs and reverse their immunosuppressive microenvironment are expected to be developed for the treatment of solid tumors, including colorectal cancer.

oncology,hematology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the interaction between colorectal cancer stem cells (CSCs) and immune cells and their roles in tumorigenesis, and to propose treatment strategies for colorectal CSCs. Specifically, the paper focuses on the following aspects:

1. **Characteristics of Colorectal CSCs**:
- **Surface Markers**: Such as CD44, CD133, Lgr5 and DCLK1, etc. These markers play a crucial role in the identification, isolation and functional analysis of CSCs.
- **Signaling Pathways**: The activation of signaling pathways such as Wnt/β - catenin, Hippo/Yap1, JAK/STAT and Notch is essential for the self - renewal and differentiation of CSCs.
- **Epigenetic Modifications**: Including the roles of DNA methylation, histone modification, chromatin remodeling and non - coding RNA. These modifications regulate various biological processes of CSCs.

2. **Interaction between CSCs and Immune Cells**:
- **Immune Escape**: CSCs escape immune surveillance by low - expressing MHC molecules and high - expressing immune checkpoint molecules (such as PD - L1).
- **Immune Microenvironment**: CSCs interact with immune cells in the tumor microenvironment, affecting tumor initiation, maintenance, metastasis and drug resistance.

3. **Treatment Strategies for CSCs**:
- Methods such as **Monoclonal Antibodies**, **Antibody - Drug Conjugates**, **Bispecific Antibodies**, **Tumor Vaccines**, **Adoptive Cell Therapies** and **Small - Molecule Inhibitors** are evaluated for targeting CSCs.
- **Multidisciplinary Integration**: With the development of CSCs and tumor microenvironment - targeting technologies and the integration of multidisciplinary research, new therapies are expected to eliminate CSCs and reverse their immunosuppressive microenvironments, thereby treating solid tumors including colorectal cancer.

Through these studies, the paper aims to reveal the complex interaction mechanisms between CSCs and immune cells and provide theoretical and experimental bases for the development of more effective treatment methods for colorectal cancer.